AbstractThe African Green Monkey (AGM) model was used to analyze the role of complement in neutralization of parainfluenza virus. Parainfluenza virus 5 (PIV5) and human parainfluenza virus type 2 were effectively neutralized in vitro by naïve AGM sera, but neutralizing capacity was lost by heat-inactivation. The mechanism of neutralization involved formation of massive aggregates, with no evidence of virion lysis. Following inoculation of the respiratory tract with a PIV5 vector expressing HIV gp160, AGM produced high levels of serum and tracheal antibodies against gp120 and the viral F and HN proteins. However, in the absence of complement these anti-PIV5 antibodies had very poor neutralizing capacity. Virions showed extensive deposition o...
AbstractWe previously used human parainfluenza virus type 3 (HPIV3) as a vector to express the Ebola...
In wild-type human parainfluenza virus type 2 (WT HPIV2), one gene (the P/V gene) encodes both the p...
Broadly cross-reactive neutralizing antibodies (bNabs) represent powerful tools to combat human immu...
AbstractThe African Green Monkey (AGM) model was used to analyze the role of complement in neutraliz...
Background: We investigated the interplay between complement and antibodies upon priming with single...
AbstractHuman parainfluenza virus type 1 (HPIV1), a major cause of croup in infants and young childr...
Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease....
Human parainfluenza virus type 1 (HPIV1), a major cause of croup in infants and young children, acco...
The antiviral properties of broadly neutralizing antibodies against HIV are well-documented but no v...
Even though the relative contribution of neutralizing antibodies (Nab) to prevent progression to AID...
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV)...
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV)...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
The antiviral neutralizing activity of sera from primate lentivirus-infected human and monkey hosts ...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
AbstractWe previously used human parainfluenza virus type 3 (HPIV3) as a vector to express the Ebola...
In wild-type human parainfluenza virus type 2 (WT HPIV2), one gene (the P/V gene) encodes both the p...
Broadly cross-reactive neutralizing antibodies (bNabs) represent powerful tools to combat human immu...
AbstractThe African Green Monkey (AGM) model was used to analyze the role of complement in neutraliz...
Background: We investigated the interplay between complement and antibodies upon priming with single...
AbstractHuman parainfluenza virus type 1 (HPIV1), a major cause of croup in infants and young childr...
Human parainfluenza viruses (HPIVs) are common causes of severe pediatric respiratory viral disease....
Human parainfluenza virus type 1 (HPIV1), a major cause of croup in infants and young children, acco...
The antiviral properties of broadly neutralizing antibodies against HIV are well-documented but no v...
Even though the relative contribution of neutralizing antibodies (Nab) to prevent progression to AID...
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV)...
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV)...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
The antiviral neutralizing activity of sera from primate lentivirus-infected human and monkey hosts ...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
AbstractWe previously used human parainfluenza virus type 3 (HPIV3) as a vector to express the Ebola...
In wild-type human parainfluenza virus type 2 (WT HPIV2), one gene (the P/V gene) encodes both the p...
Broadly cross-reactive neutralizing antibodies (bNabs) represent powerful tools to combat human immu...